Title

BCP Meeting - March 16, 2017

Announcement Description

Biotechnology/Chemical/Pharmaceutical Customer Partnership

 

Thursday, March 16, 2017

United States Patent and Trademark Office

USPTO Main Campus (Alexandria), Madison Auditorium

 

 

10:00 – 10:10am (EDT)

Welcoming and Opening Remarks

Jerry Lorengo

Director, TC1600, USPTO

 

Daniel Sullivan

Director, TC1600, USPTO

 

Wanda Walker

Director, TC1600, USPTO

 

 

10:10 – 11:10am (EDT)

Rationale Statements in 35 U.S.C. 103

Cassandra Spyrou, Supervisory Review Quality Assurance Specialist, OPQA, USPTO

 

 

 

11:10am – 12:00pm (EDT)

The Role of Inherency in Making an Obviousness Determination

William Smith, Of Counsel, BakerHostetler

 

 

 

 

 

 

12:00 – 1:00pm (EDT)

BREAK

Lunch

 

 

 

 

 

 

 

1:002:00pm (EDT)

Range Analysis

Jean Witz, SPE, CRU, USPTO

 

 

 

2:00 – 2:40pm (EDT)

 

37 CFR §1.132 Practice, Unexpected Results

Scarlett Goon, QAS, TC1600, USPTO

 

 

 

2:40 – 2:50pm (EDT)

 

BREAK

 

 

 

 

2:50 – 3:50pm (EDT)

Interviews (From the Startup Perspective)

Charles Andres, Associate, Patent and Innovation, WSGR

 

 

 

 

3:50 – 4:30pm (EDT)

Interview Training (USPTO)

 

Frederick Krass, SPE, TC1600, USPTO

 

 

 

 

4:30 – 4:40pm (EDT)

 

Closing Remarks

Directors, TC1600, USPTO

 

 

 

 

 

Expires

3/16/2017

Attachments

Created at 3/23/2017 10:01 PM by John Marquardt
Last modified at 3/23/2017 10:01 PM by John Marquardt